146 related articles for article (PubMed ID: 26077226)
41. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
[TBL] [Abstract][Full Text] [Related]
42. The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.
Ketabi Z; Gerdes AM; Mosgaard B; Ladelund S; Bernstein I
Gynecol Oncol; 2014 Jun; 133(3):526-30. PubMed ID: 24631699
[TBL] [Abstract][Full Text] [Related]
43. Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome.
Therkildsen C; Ladelund S; Rambech E; Persson A; Petersen A; Nilbert M
Eur J Neurol; 2015 Apr; 22(4):717-24. PubMed ID: 25648859
[TBL] [Abstract][Full Text] [Related]
44. Risk of breast cancer in Lynch syndrome: a systematic review.
Win AK; Lindor NM; Jenkins MA
Breast Cancer Res; 2013 Mar; 15(2):R27. PubMed ID: 23510156
[TBL] [Abstract][Full Text] [Related]
45. Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer?
Bharati R; Jenkins MA; Lindor NM; Le Marchand L; Gallinger S; Haile RW; Newcomb PA; Hopper JL; Win AK
Gynecol Oncol; 2014 May; 133(2):287-92. PubMed ID: 24631449
[TBL] [Abstract][Full Text] [Related]
46. Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis.
Ryan S; Jenkins MA; Win AK
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):437-49. PubMed ID: 24425144
[TBL] [Abstract][Full Text] [Related]
47. Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes.
van Vliet CM; Dowty JG; van Vliet JL; Smith L; Mead LJ; Macrae FA; St John DJ; Giles GG; Southey MC; Jenkins MA; Velan GM; Hopper JL
Hum Mutat; 2011 Feb; 32(2):207-12. PubMed ID: 21120946
[TBL] [Abstract][Full Text] [Related]
48. Elevated risk of prostate cancer among men with Lynch syndrome.
Raymond VM; Mukherjee B; Wang F; Huang SC; Stoffel EM; Kastrinos F; Syngal S; Cooney KA; Gruber SB
J Clin Oncol; 2013 May; 31(14):1713-8. PubMed ID: 23530095
[TBL] [Abstract][Full Text] [Related]
49. The spectrum of urological malignancy in Lynch syndrome.
Barrow PJ; Ingham S; O'Hara C; Green K; McIntyre I; Lalloo F; Hill J; Evans DG
Fam Cancer; 2013 Mar; 12(1):57-63. PubMed ID: 23054215
[TBL] [Abstract][Full Text] [Related]
50. Cancer risk in mutation carriers of DNA-mismatch-repair genes.
Aarnio M; Sankila R; Pukkala E; Salovaara R; Aaltonen LA; de la Chapelle A; Peltomäki P; Mecklin JP; Järvinen HJ
Int J Cancer; 1999 Apr; 81(2):214-8. PubMed ID: 10188721
[TBL] [Abstract][Full Text] [Related]
51. Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome.
Win AK; Clendenning M; Crawford W; Rosty C; Preston SG; Southey MC; Parry S; Giles GG; Macrae FA; Winship IM; Baron JA; Hopper JL; Jenkins MA; Buchanan DD
Genes Cancer; 2015 Nov; 6(11-12):445-51. PubMed ID: 26807197
[TBL] [Abstract][Full Text] [Related]
52. Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario.
Choi YH; Cotterchio M; McKeown-Eyssen G; Neerav M; Bapat B; Boyd K; Gallinger S; McLaughlin J; Aronson M; Briollais L
Hered Cancer Clin Pract; 2009 Aug; 7(1):14. PubMed ID: 19698169
[TBL] [Abstract][Full Text] [Related]
53. Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.
Dinh TA; Rosner BI; Atwood JC; Boland CR; Syngal S; Vasen HF; Gruber SB; Burt RW
Cancer Prev Res (Phila); 2011 Jan; 4(1):9-22. PubMed ID: 21088223
[TBL] [Abstract][Full Text] [Related]
54. Fertility after young-onset colorectal cancer: a study of subjects with Lynch syndrome.
Stupart D; Win AK; Winship IM; Jenkins M
Colorectal Dis; 2015 Sep; 17(9):787-93. PubMed ID: 25754680
[TBL] [Abstract][Full Text] [Related]
55. Physical activity and the risk of colorectal cancer in Lynch syndrome.
Dashti SG; Win AK; Hardikar SS; Glombicki SE; Mallenahalli S; Thirumurthi S; Peterson SK; You YN; Buchanan DD; Figueiredo JC; Campbell PT; Gallinger S; Newcomb PA; Potter JD; Lindor NM; Le Marchand L; Haile RW; Hopper JL; Jenkins MA; Basen-Engquist KM; Lynch PM; Pande M
Int J Cancer; 2018 Nov; 143(9):2250-2260. PubMed ID: 29904935
[TBL] [Abstract][Full Text] [Related]
56. Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types.
Therkildsen C; Ladelund S; Smith-Hansen L; Lindberg LJ; Nilbert M
Br J Cancer; 2017 Nov; 117(11):1702-1710. PubMed ID: 29065108
[TBL] [Abstract][Full Text] [Related]
57. Cumulative incidence of metachronous colorectal cancer risk for mismatch repair gene mutation carriers is overestimated.
Renehan AG
Gut; 2012 May; 61(5):783; author reply 783-4. PubMed ID: 21873468
[No Abstract] [Full Text] [Related]
58. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.
Win AK; Cleary SP; Dowty JG; Baron JA; Young JP; Buchanan DD; Southey MC; Burnett T; Parfrey PS; Green RC; Le Marchand L; Newcomb PA; Haile RW; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
Int J Cancer; 2011 Nov; 129(9):2256-62. PubMed ID: 21171015
[TBL] [Abstract][Full Text] [Related]
59. The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care.
Møller P
Hered Cancer Clin Pract; 2020; 18():6. PubMed ID: 32190163
[TBL] [Abstract][Full Text] [Related]
60. Correction:
Gut; 2020 Jun; 69(6):e4. PubMed ID: 32381558
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
